Research Library

In a study for the British Journal of Political Science, the authors found that Muslim religious leaders weaken their perceived religious authority when they engage with politics.

Companies developing stem cell-based interventions should work with policymakers and patient advocates to address risks for current and future patients and to protect clinical research and the reputation of the field, write the authors. Read their full article in Cell & Gene Therapy Insights (free registration).

The authors assess the impact of Mexico's 2014 energy reform on consumer welfare.

It now seems technically feasible to culture human embryos beyond the “fourteen‐day limit,” which has the potential to increase scientific understanding of human development and perhaps improve infertility treatments. Robust stakeholder engagement preceded adoption of the fourteen‐day limit and should arguably be part of efforts to reassess it, write the authors.

This study leverages validated patient-reported outcomes measures  to analyze the association between "financial toxicity" and quality of life and satisfaction among women undergoing ablative breast cancer surgery. Journal of the American College of Surgeons

The authors assess U.S. health care system and offer a plan for achieving universal health care. The Lancet: http://bit.ly/2lSaqX6

By Morgan N. Fredell, Hagop M. Kantarjian, Ya-Chen Shih, Vivian Ho and Binata Mukherjee Current U.S. health care spending includes many areas of wasted expenditures. In this study, published in Cancer, the authors explore plans to optimize U.S. health care to provide greater benefits to patients: https://bit.ly/2TmeoDg

The article analyzes the spread of neglected tropical diseases in Somolia due to severe poverty, and civil strife, and discusses the need for reforms to the country’s health systems and infrastructure.

Enhancement of American science, technology, engineering, and math education (STEM) at all levels, even early childhood, is a justifiable federal priority.

Every patient with cancer or another life-threatening disease wants the most effective treatment, but drug prices have become staggering. What determines the escalating prices of cancer drugs?